Biomark Diagnostics Market Cap

Biomark Diagnostics has a market cap or net worth of $41.4 million as of February 12, 2026. Its market cap has increased by 249.56% in one year.

Market Cap

41.40M

Enterprise Value

40.86M

Revenue

88.61K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.37

Market Cap Chart

Since November 27, 2014, Biomark Diagnostics's market cap has increased from 35.57M to 41.40M, an increase of 16.39%. That is a compound annual growth rate of 1.36%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	41.40M	8.02%
Dec 30, 2025	38.32M	272.83%
Dec 30, 2024	10.28M	-24.05%
Dec 29, 2023	13.53M	27.76%
Dec 30, 2022	10.59M	-28.16%
Dec 30, 2021	14.74M	116.26%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Global Cord Blood	127.22M
China New Energy Group Company	73.43M
Interpace Biosciences	51.24M
Bioqual	33.55M
Longduoduo Company	17.81M
Aspira Women's Health	17.04M
Psychemedics	10.16M
Hypha Labs	5.13M

Market Cap Rankings